Feb. 19, 2018
Summit Pharmaceuticals International Corporation
Joint Business in Cosmetic ODM Business in Japan between Intercos S.p.A and Sumitomo Corporation Group
Intercos S.p.A (Headquarter: Italy, CEO Dario Ferrari), Sumitomo Corporation(Headquarter: Tokyo, Japan, CEO Kuniharu Nakamura), and Summit Pharmaceuticals Internation(Headquarter: Tokyo, Japan, CEO Kenichi Nakamura) have agreed to start Joint business related to Cosmetic ODM in Japan.
Cosmetic market (retail base) in Japan is said around US$24-25 billion, and expected to continue the market growth, under the In-bound demand in addition to the organic growth. And there is some new trend that the Japanese Quality, including quality control/assurance are highly appreciated by consumers. Cosmetic OEM, ODM industry in Japan is also expected to take more roles/functions for the further market growth in Japan, under the various market changes, such as the shortening product development time, various new comers from different industries into Cosmetic market.
Intercos is the leading company in the global ODM(original design manufacturing) market, active in the production of Color Cosmetic, Skin care, Active Ingredients and Toiletries. Born in 1972, the company currently accounts for more than 430 clients globally, able to deliver a full service approach, from product design and concept creation, to manufacturing of finished products, and through Intercos Concept, even branding and retailing support.
Intercos strength lies in its unrivalled, proprietary innovation: more than 880 people among the 11 R&D sites globally and 15 marketing offices, delivering over 1,000 new formulas every year and anticipating trends, with the vision of imagining the future of beauty for every consumer in the world. Unique among ODMs, Intercos has the biggest and most diversified global capacity: with 15 plants in Europe, USA, Brazil, China and Korea able to serve all product categories, including an overall capacity of 15,000 bulk tons and over 1.6 billion pieces.
Intercos is very happy to enhance the full service in Japan, together with Sumitomo Corporation Group as a business partner, further enhancing their mutual strenghts.
Intercos and Sumitomo Corporation group has a plan to start up R&D activity in order to give technical services to the local clients, and to open show room in Tokyo area in year 2018, and Wishing to contribute to the worldwide beauty and health innovation.
|Address||:||registered office||: Milan, Piazza Generale Armando Diaz n. 1, Milan (Italy)|
|Administrative office||:||Via G. Marconi n. 84 Agrate Brianza (Italy)|
|Representative||:||Dario Gianandrea Ferrari|
|Address||:||8-11 Harumi-1 chome, Chiyoda-ku, Tokyo 104-8610 Japan|
|■ Summi Pharmaceuticals International|
|Address||:||1-2-2, Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 Japan|
■Sumitomo Corporation’s Material Issues
Sumitomo Corporation Group positions “Six Material Issues to Achieve Sustainable Growth with Society” as an important factor in developing business strategies and in the decision-making process for individual businesses. Going forward, we will pursue sustainable growth by resolving these issues through our business activities. This Project especially contributes to “the Development of Local Communities and Industries” and “Establishing a Foundation for Comfortable and Enriching Lifestyles”.